0001179110-20-005186.txt : 20200428 0001179110-20-005186.hdr.sgml : 20200428 20200428172550 ACCESSION NUMBER: 0001179110-20-005186 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200424 FILED AS OF DATE: 20200428 DATE AS OF CHANGE: 20200428 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NOVAKOVIC PHEBE N CENTRAL INDEX KEY: 0001222195 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 20826289 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 2246676100 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 4 1 edgar.xml FORM 4 - X0306 4 2020-04-24 0 0000001800 ABBOTT LABORATORIES ABT 0001222195 NOVAKOVIC PHEBE N C/O GENERAL DYNAMICS CORPORATION 11011 SUNSET HILLS ROAD RESTON VA 20190 1 0 0 0 Common shares without par value 2020-04-24 4 A 0 1974 0 A 28307 D Option (right to buy) 93.68 2020-04-24 4 A 0 9030 0 A 2020-04-24 2030-04-23 Common shares 9030 9030 D These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Jessica H. Paik, by Power of Attorney for Phebe N. Novakovic 2020-04-28